Emond J, De Luca T
Columbia College of Physicians and Surgeons, New York Presbyterian Hospital, New York, USA.
Minerva Chir. 2000 Nov;55(11):759-69.
Living relative liver transplantation is a valid alternative to cadaver transplantation especially at a time when the availability of organs cannot meet the requests of long waiting lists. This procedure was initially introduced in response to the shortage of organs for pediatric cases, but the rapid growth of demand for liver transplantation has led to its extension to the adult population. The procedure raises a number of ethical, logistic and technical questions. The ethical aspect has been widely debated and in order to be acceptable, the procedure must comply with three critical points: the need for innovation, an acceptable risk-benefit ratio and adequate informed consent. The technical aspect is essential for the success of the procedure. It calls for an extensive experience and know-how of hepatobiliary surgery on one hand, and the use of high-resolution vision on the other, an aspect which is crucial for the success of vascular anastomoses. The indications for living relative transplantation are the same as for standard transplants. The sole exception is for adult patients with 2A status who present advanced hepatic imbalance caused by chronic liver disease, thereby reducing the probability of success, above all because a living donor graft is always smaller compared to the ideal dimensions for the recipient. In view of the severe shortage of organs, living relative transplantation is an important alternative for both pediatric and adult patients. The challenge over the coming decades will be to extend living relative transplantation to a growing number of patients, without jeopardizing the health of the donor.
活体亲属肝移植是尸体肝移植的一种有效替代方案,尤其是在器官供应无法满足漫长等待名单上患者需求的时期。该手术最初是为应对儿科病例的器官短缺而引入的,但肝移植需求的快速增长已导致其应用范围扩大到成人。该手术引发了一些伦理、后勤和技术问题。伦理方面已得到广泛辩论,为了被接受,该手术必须符合三个关键点:创新的必要性、可接受的风险效益比以及充分的知情同意。技术方面对手术的成功至关重要。一方面需要肝胆外科的丰富经验和专业知识,另一方面需要使用高分辨率视野,这对于血管吻合的成功至关重要。活体亲属移植的适应症与标准移植相同。唯一的例外是2A级成年患者,他们因慢性肝病出现严重的肝脏失衡,从而降低了成功的概率,尤其是因为活体供体移植物与受体的理想尺寸相比总是较小。鉴于器官严重短缺,活体亲属移植对于儿科和成年患者来说都是一种重要的替代方案。未来几十年的挑战将是在不危及供体健康的情况下,将活体亲属移植扩展到越来越多的患者。